Norovirus GII.4 antibodies in the Portuguese population

被引：6
|
作者：
Mesquita, Joao R. [1 ,2 ]
Nascimento, Maria S. J. [2 ,3 ]
机构：
[1] Inst Politecn Viseu, Escola Super Agr, P-3500606 Ranhados, Viseu, Portugal
[2] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal
[3] Univ Porto, Fac Farm, Dept Ciencias Biol, Microbiol Lab, P-4100 Oporto, Portugal
来源：
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2014年 / 8卷 / 09期
关键词：
norovirus; antibodies; Portugal; foodborne diseases; UNITED-STATES; SEROEPIDEMIOLOGY; GASTROENTERITIS; PATHOGENS; OUTBREAKS; ILLNESS;
D O I：
10.3855/jidc.4616
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Introduction: Norovirus GII.4 is the leading cause of outbreaks of acute and sporadic acute gastroenteritis worldwide. Information on the prevalence of norovirus in Portugal is scarce or null. Methodology: We used a GII.4 norovirus virus-like particle-based enzyme immune assay to measure the seropositivity rate of GII.4 norovirus. Results: A total of 342 (70%) out of 473 serum samples tested positive for anti-GII.4 norovirus IgG. No statistically significant differences were found between regions, sex and age groups. Conclusion: Norovirus GII.4 infections are frequent in Portugal.
引用
收藏
页码：1201 / 1204
页数：4
相关论文
共 50 条
  • [41] Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies
    Moeini, Hassan
    Afridi, Suliman Qadir
    Donakonda, Sainitin
    Knolle, Percy A.
    Protzer, Ulrike
    Hoffmann, Dieter
    VACCINES, 2021, 9 (01) : 1 - 18
  • [42] Comparative Evolution of GII.3 and GII.4 Norovirus over a 31-Year Period
    Boon, Denali
    Mahar, Jackie E.
    Abente, Eugenio J.
    Kirkwood, Carl D.
    Purcell, Robert H.
    Kapikian, Albert Z.
    Green, Kim Y.
    Bok, Karin
    JOURNAL OF VIROLOGY, 2011, 85 (17) : 8656 - 8666
  • [43] Genetic Susceptibility to Norovirus GII.3 and GII.4 Infections in Chinese Pediatric Diarrheal Disease
    Liu, Pengbo
    Wang, Xiaoqin
    Lee, Joong-Chul
    Teunis, Peter
    Hu, Senke
    Paradise, Helen Tang
    Moe, Christine
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (11) : E305 - E309
  • [44] Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine
    Yu, Zhendi
    Shao, Qingyi
    Xu, Zhangkai
    Chen, Chenghao
    Li, Mingfan
    Jiang, Yi
    Cheng, Dongqing
    VACCINES, 2023, 11 (06)
  • [45] Complete genome analysis of a novel norovirus GII.4 variant identified in China
    Xue, Liang
    Wu, Qingping
    Kou, Xiaoxia
    Cai, Weicheng
    Zhang, Jumei
    Guo, Weipeng
    VIRUS GENES, 2013, 47 (02) : 228 - 234
  • [46] Subcellular Localization and Functional Characterization of GII.4 Norovirus-Encoded NTPase
    Yen, Ju-Bei
    Wei, Ling-Huei
    Chen, Lee-Wen
    Chen, Li-Yu
    Hung, Chien-Hui
    Wang, Shie-Shan
    Chang, Pey-Jium
    JOURNAL OF VIROLOGY, 2018, 92 (05)
  • [47] Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera
    Dai, Ying-Chun
    Zhang, Xu-Fu
    Xia, Ming
    Tan, Ming
    Quigley, Christina
    Lei, Wen
    Fang, Hao
    Zhong, Weiming
    Lee, Bonita
    Pang, Xiaoli
    Nie, Jun
    Jiang, Xi
    PLOS ONE, 2015, 10 (04):
  • [48] Carlow Virus, a 2002 GII.4 variant Norovirus strain from Ireland
    Karen Kearney
    John Menton
    John G Morgan
    Virology Journal, 4
  • [49] Comparative Efficacy of Seven Hand Sanitizers against Murine Norovirus, Feline Calicivirus, and GII.4 Norovirus
    Park, Geun Woo
    Barclay, Leslie
    Macinga, David
    Charbonneau, Duane
    Pettigrew, Charles A.
    Vinje, Jan
    JOURNAL OF FOOD PROTECTION, 2010, 73 (12) : 2232 - 2238
  • [50] Emergence of a Norovirus GII.4 Strain Correlates with Changes in Evolving Blockade Epitopes
    Lindesmith, Lisa C.
    Costantini, Veronica
    Swanstrom, Jesica
    Debbink, Kari
    Donaldson, Eric F.
    Vinje, Jan
    Baric, Ralph S.
    JOURNAL OF VIROLOGY, 2013, 87 (05) : 2803 - 2813
12345